Literature DB >> 10722682

Interaction between the conserved region in the C-terminal domain of GRK2 and rhodopsin is necessary for GRK2 to catalyze receptor phosphorylation.

X Q Gan1, J Y Wang, Q H Yang, Z Li, F Liu, G Pei, L Li.   

Abstract

The C-terminal domain of G protein-coupled receptor kinases (GRKs) consists of a conserved region and a variable region, and the variable region has been shown to direct the membrane translocation of cytosolic enzymes. The present work has revealed that the C-terminal domain may also be involved in kinase-receptor interaction that is primarily mediated by the conserved region. Truncation of the C-terminal domain or deletion of the conserved region in this domain of GRK2 resulted in a complete loss of its ability to phosphorylate rhodopsin and in an obvious decrease in its sensitivity to receptor-mediated phosphorylation of a peptide substrate. On the contrary, deletion of the betagamma subunit binding region in the C-terminal domain of GRK2 did not significantly alter the ability of the enzyme to phosphorylate rhodopsin. In addition, the recombinant proteins that represent the C-terminal domain and the conserved region of GRK2 could inhibit GRK2-mediated phosphorylation of rhodopsin and receptor-mediated activation of GRK2 but not GRK2-mediated phosphorylation of the peptide substrate. Furthermore, the conserved region as well as the C-terminal domain could directly bind rhodopsin in vitro. These results indicate that the C-terminal domain, or more precisely, the conserved region of this domain, is important for enzyme-receptor interaction and that this interaction is required for GRK2 to catalyze receptor phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722682     DOI: 10.1074/jbc.275.12.8469

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  G protein-coupled receptor kinases: Past, present and future.

Authors:  Konstantin E Komolov; Jeffrey L Benovic
Journal:  Cell Signal       Date:  2017-07-12       Impact factor: 4.315

Review 2.  The cytoplasmic rhodopsin-protein interface: potential for drug discovery.

Authors:  Naveena Yanamala; Eric Gardner; Alec Riciutti; Judith Klein-Seetharaman
Journal:  Curr Drug Targets       Date:  2012-01       Impact factor: 3.465

3.  Expression, purification, and analysis of G-protein-coupled receptor kinases.

Authors:  Rachel Sterne-Marr; Alison I Baillargeon; Kevin R Michalski; John J G Tesmer
Journal:  Methods Enzymol       Date:  2013       Impact factor: 1.600

4.  Characterization of a hyperphosphorylated variant of G protein-coupled receptor kinase 5 expressed in E. coli.

Authors:  Tyler S Beyett; Qiuyan Chen; Emily J Labudde; Joseph Krampen; Prateek V Sharma; John J G Tesmer
Journal:  Protein Expr Purif       Date:  2019-11-29       Impact factor: 1.650

5.  GRK2 activation by receptors: role of the kinase large lobe and carboxyl-terminal tail.

Authors:  Rachel Sterne-Marr; P Alex Leahey; Jamee E Bresee; Heather M Dickson; Wesley Ho; Michael J Ragusa; Ryan M Donnelly; Sarah M Amie; Janet A Krywy; Elizabeth D Brookins-Danz; Somtochukwu C Orakwue; Michael J Carr; Kae Yoshino-Koh; Qianzhi Li; John J G Tesmer
Journal:  Biochemistry       Date:  2009-05-26       Impact factor: 3.162

Review 6.  G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases.

Authors:  Cristina Murga; Alba C Arcones; Marta Cruces-Sande; Ana M Briones; Mercedes Salaices; Federico Mayor
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

Review 7.  G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub.

Authors:  Petronila Penela; Catalina Ribas; Francisco Sánchez-Madrid; Federico Mayor
Journal:  Cell Mol Life Sci       Date:  2019-08-20       Impact factor: 9.261

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.